$VRTX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in VERTEX PHARMACEUTICALS INC / MA. Get notifications about new insider transactions in VERTEX PHARMACEUTICALS INC / MA for free.

Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 46 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Tatsis Ourania	SVP, CRO	Sell	S	235.39	160	37,662	12,978	13.1 K to 13 K (-1.22 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Tatsis Ourania	SVP, CRO	Sell	S	234.43	240	56,263	13,138	13.4 K to 13.1 K (-1.79 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Tatsis Ourania	SVP, CRO	Sell	S	232.43	80	18,594	13,378	13.5 K to 13.4 K (-0.59 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Tatsis Ourania	SVP, CRO	Sell	S	231.82	160	37,091	13,458	13.6 K to 13.5 K (-1.17 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Tatsis Ourania	SVP, CRO	Sell	S	229.57	416	95,501	13,618	14 K to 13.6 K (-2.96 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Tatsis Ourania	SVP, CRO	Payment of Exercise	F	239.23	1,036	247,842	14,034	15.1 K to 14 K (-6.87 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	238.40	150	35,760	14,932	15.1 K to 14.9 K (-0.99 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	236.85	90	21,317	15,082	15.2 K to 15.1 K (-0.59 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	235.49	150	35,324	15,172	15.3 K to 15.2 K (-0.98 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	234.50	150	35,175	15,322	15.5 K to 15.3 K (-0.97 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	232.40	120	27,888	15,472	15.6 K to 15.5 K (-0.77 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	231.17	137	31,670	15,592	15.7 K to 15.6 K (-0.87 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	229.66	283	64,994	15,729	16 K to 15.7 K (-1.77 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Payment of Exercise	F	239.23	864	206,695	16,012	16.9 K to 16 K (-5.12 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	238.33	540	128,698	32,915	33.5 K to 32.9 K (-1.61 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	236.63	180	42,593	33,455	33.6 K to 33.5 K (-0.54 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	235.75	360	84,870	33,635	34 K to 33.6 K (-1.06 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	234.56	533	125,020	33,995	34.5 K to 34 K (-1.54 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	233.18	90	20,986	34,528	34.6 K to 34.5 K (-0.26 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	232.62	450	104,679	34,618	35.1 K to 34.6 K (-1.28 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	230.98	270	62,365	35,068	35.3 K to 35.1 K (-0.76 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	230.00	953	219,190	35,338	36.3 K to 35.3 K (-2.63 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Payment of Exercise	F	239.23	3,156	755,010	36,291	39.4 K to 36.3 K (-8.00 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	238.30	480	114,384	26,838	27.3 K to 26.8 K (-1.76 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	236.26	320	75,603	27,318	27.6 K to 27.3 K (-1.16 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	234.77	640	150,253	27,638	28.3 K to 27.6 K (-2.26 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	232.89	320	74,525	28,278	28.6 K to 28.3 K (-1.12 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	231.62	330	76,435	28,598	28.9 K to 28.6 K (-1.14 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	230.07	938	215,806	28,928	29.9 K to 28.9 K (-3.14 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Payment of Exercise	F	239.23	2,416	577,980	29,866	32.3 K to 29.9 K (-7.48 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	238.33	1,680	400,394	92,581	94.3 K to 92.6 K (-1.78 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	236.63	560	132,513	94,261	94.8 K to 94.3 K (-0.59 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	235.53	1,210	284,991	94,821	96 K to 94.8 K (-1.26 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	234.49	1,640	384,564	96,031	97.7 K to 96 K (-1.68 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	232.96	1,017	236,920	97,671	98.7 K to 97.7 K (-1.03 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	231.76	1,050	243,348	98,688	99.7 K to 98.7 K (-1.05 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	230.40	1,120	258,048	99,738	100.9 K to 99.7 K (-1.11 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	229.77	2,273	522,267	100,858	103.1 K to 100.9 K (-2.20 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Payment of Exercise	F	239.23	8,410	2,011,924	103,131	111.5 K to 103.1 K (-7.54 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Sell	S	239.13	111	26,543	26,626	26.7 K to 26.6 K (-0.42 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Sell	S	238.28	420	100,078	26,737	27.2 K to 26.7 K (-1.55 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Sell	S	236.71	320	75,747	27,157	27.5 K to 27.2 K (-1.16 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Sell	S	235.36	340	80,022	27,477	27.8 K to 27.5 K (-1.22 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Sell	S	234.41	660	154,711	27,817	28.5 K to 27.8 K (-2.32 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Sell	S	232.35	440	102,234	28,477	28.9 K to 28.5 K (-1.52 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Sell	S	230.88	450	103,896	28,917	29.4 K to 28.9 K (-1.53 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Sell	S	229.72	893	205,140	29,367	30.3 K to 29.4 K (-2.95 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Payment of Exercise	F	239.23	2,898	693,289	30,260	33.2 K to 30.3 K (-8.74 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Bozic Carmen	EVP, GMDA	Payment of Exercise	F	239.23	216	51,674	14,302	14.5 K to 14.3 K (-1.49 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	238.33	632	150,625	35,179	35.8 K to 35.2 K (-1.76 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	236.88	20	4,738	35,811	35.8 K to 35.8 K (-0.06 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	236.36	420	99,271	35,831	36.3 K to 35.8 K (-1.16 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	235.14	540	126,976	36,251	36.8 K to 36.3 K (-1.47 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	234.08	420	98,314	36,791	37.2 K to 36.8 K (-1.13 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	232.35	360	83,646	37,211	37.6 K to 37.2 K (-0.96 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	230.85	432	99,727	37,571	38 K to 37.6 K (-1.14 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	229.78	810	186,122	38,003	38.8 K to 38 K (-2.09 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Payment of Exercise	F	239.23	2,898	693,289	38,813	41.7 K to 38.8 K (-6.95 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	238.33	480	114,398	28,902	29.4 K to 28.9 K (-1.63 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	236.80	160	37,888	29,382	29.5 K to 29.4 K (-0.54 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	235.53	280	65,948	29,542	29.8 K to 29.5 K (-0.94 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	234.52	574	134,614	29,822	30.4 K to 29.8 K (-1.89 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	232.51	400	93,004	30,396	30.8 K to 30.4 K (-1.30 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	230.77	400	92,308	30,796	31.2 K to 30.8 K (-1.28 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	229.72	734	168,614	31,196	31.9 K to 31.2 K (-2.30 %)
Feb 26 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Payment of Exercise	F	239.23	2,416	577,980	31,930	34.3 K to 31.9 K (-7.03 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	245.74	202	49,639	16,876	17.1 K to 16.9 K (-1.18 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	245.00	280	68,600	17,078	17.4 K to 17.1 K (-1.61 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	243.85	202	49,258	17,358	17.6 K to 17.4 K (-1.15 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	242.80	640	155,392	17,560	18.2 K to 17.6 K (-3.52 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	241.95	240	58,068	18,200	18.4 K to 18.2 K (-1.30 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Payment of Exercise	F	241.50	1,248	301,392	18,440	19.7 K to 18.4 K (-6.34 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	245.82	249	61,209	39,447	39.7 K to 39.4 K (-0.63 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	245.15	720	176,508	39,696	40.4 K to 39.7 K (-1.78 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	244.08	540	131,803	40,416	41 K to 40.4 K (-1.32 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	242.85	1,260	305,991	40,956	42.2 K to 41 K (-2.98 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	242.04	720	174,269	42,216	42.9 K to 42.2 K (-1.68 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Payment of Exercise	F	241.50	3,262	787,773	42,936	46.2 K to 42.9 K (-7.06 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	245.52	694	170,391	32,282	33 K to 32.3 K (-2.10 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	244.64	416	101,770	32,976	33.4 K to 33 K (-1.25 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	243.59	560	136,410	33,392	34 K to 33.4 K (-1.65 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	242.64	1,098	266,419	33,952	35.1 K to 34 K (-3.13 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	241.75	360	87,030	35,050	35.4 K to 35.1 K (-1.02 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Payment of Exercise	F	241.50	2,496	602,784	35,410	37.9 K to 35.4 K (-6.58 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Sell	S	245.75	129	31,702	33,158	33.3 K to 33.2 K (-0.39 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Sell	S	244.94	260	63,684	33,287	33.5 K to 33.3 K (-0.78 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Sell	S	243.76	134	32,664	33,547	33.7 K to 33.5 K (-0.40 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Sell	S	242.62	540	131,015	33,681	34.2 K to 33.7 K (-1.58 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Sell	S	241.71	120	29,005	34,221	34.3 K to 34.2 K (-0.35 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Kewalramani Reshma	EVP and CMO	Payment of Exercise	F	241.50	944	227,976	34,341	35.3 K to 34.3 K (-2.68 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	245.76	377	92,652	41,711	42.1 K to 41.7 K (-0.90 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	245.04	580	142,123	42,088	42.7 K to 42.1 K (-1.36 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	243.76	400	97,504	42,668	43.1 K to 42.7 K (-0.93 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	242.91	1,011	245,582	43,068	44.1 K to 43.1 K (-2.29 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	242.08	760	183,981	44,079	44.8 K to 44.1 K (-1.69 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Payment of Exercise	F	241.50	2,496	602,784	44,839	47.3 K to 44.8 K (-5.27 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	245.57	556	136,537	34,346	34.9 K to 34.3 K (-1.59 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	244.87	632	154,758	34,902	35.5 K to 34.9 K (-1.78 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	243.66	530	129,140	35,534	36.1 K to 35.5 K (-1.47 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	242.62	1,010	245,046	36,064	37.1 K to 36.1 K (-2.72 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	241.80	400	96,720	37,074	37.5 K to 37.1 K (-1.07 %)
Feb 19 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Payment of Exercise	F	241.50	2,496	602,784	37,474	40 K to 37.5 K (-6.24 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	248.45	4,609	1,145,106	132,540	137.1 K to 132.5 K (-3.36 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	247.49	7,533	1,864,342	137,149	144.7 K to 137.1 K (-5.21 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	246.27	14,433	3,554,415	144,682	159.1 K to 144.7 K (-9.07 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	245.37	14,024	3,441,069	159,115	173.1 K to 159.1 K (-8.10 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	244.56	4,124	1,008,565	173,139	177.3 K to 173.1 K (-2.33 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Sell	S	243.37	2,800	681,436	177,263	180.1 K to 177.3 K (-1.56 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	LEIDEN JEFFREY M	CEO & President	Payment of Exercise	F	240.95	36,755	8,856,117	180,063	216.8 K to 180.1 K (-16.95 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	247.93	1,102	273,219	19,688	20.8 K to 19.7 K (-5.30 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	246.84	1,120	276,461	20,790	21.9 K to 20.8 K (-5.11 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	245.89	1,700	418,013	21,910	23.6 K to 21.9 K (-7.20 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	244.90	1,560	382,044	23,610	25.2 K to 23.6 K (-6.20 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Sell	S	243.59	380	92,564	25,170	25.6 K to 25.2 K (-1.49 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Silva Paul M	SVP & Controller	Payment of Exercise	F	240.95	4,673	1,125,959	25,550	30.2 K to 25.6 K (-15.46 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	248.73	400	99,492	46,198	46.6 K to 46.2 K (-0.86 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	247.98	2,103	521,502	46,598	48.7 K to 46.6 K (-4.32 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	246.88	1,821	449,568	48,701	50.5 K to 48.7 K (-3.60 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	245.99	4,320	1,062,677	50,522	54.8 K to 50.5 K (-7.88 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	245.05	3,426	839,541	54,842	58.3 K to 54.8 K (-5.88 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Sell	S	243.53	1,000	243,530	58,268	59.3 K to 58.3 K (-1.69 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Sachdev Amit	EVP, Chief Patient ...	Payment of Exercise	F	240.95	12,215	2,943,204	59,268	71.5 K to 59.3 K (-17.09 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	248.52	1,344	334,011	37,906	39.3 K to 37.9 K (-3.42 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	247.62	2,499	618,802	39,250	41.7 K to 39.3 K (-5.99 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	246.52	3,783	932,585	41,749	45.5 K to 41.7 K (-8.31 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	245.62	6,232	1,530,704	45,532	51.8 K to 45.5 K (-12.04 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	244.67	2,102	514,296	51,764	53.9 K to 51.8 K (-3.90 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Sell	S	243.42	922	224,433	53,866	54.8 K to 53.9 K (-1.68 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Parini Michael	EVP, CL&AO	Payment of Exercise	F	240.95	13,458	3,242,705	54,788	68.2 K to 54.8 K (-19.72 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	248.62	486	120,829	47,335	47.8 K to 47.3 K (-1.02 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	247.91	1,863	461,856	47,821	49.7 K to 47.8 K (-3.75 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	246.76	1,770	436,765	49,684	51.5 K to 49.7 K (-3.44 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	245.93	3,377	830,506	51,454	54.8 K to 51.5 K (-6.16 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	244.99	2,860	700,671	54,831	57.7 K to 54.8 K (-4.96 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Sell	S	243.76	930	226,697	57,691	58.6 K to 57.7 K (-1.59 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP, Chief Commerci ...	Payment of Exercise	F	240.95	8,942	2,154,575	58,621	67.6 K to 58.6 K (-13.24 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	248.50	1,200	298,200	39,970	41.2 K to 40 K (-2.91 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	247.73	2,235	553,677	41,170	43.4 K to 41.2 K (-5.15 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	246.73	3,472	856,647	43,405	46.9 K to 43.4 K (-7.41 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	245.81	5,725	1,407,262	46,877	52.6 K to 46.9 K (-10.88 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	244.89	3,400	832,626	52,602	56 K to 52.6 K (-6.07 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Sell	S	243.36	1,000	243,360	56,002	57 K to 56 K (-1.75 %)
Feb 12 2020	VRTX	VERTEX PHARMACEUTI ...	ALTSHULER DAVID	EVP, Global Researc ...	Payment of Exercise	F	240.95	13,308	3,206,563	57,002	70.3 K to 57 K (-18.93 %)
Feb 11 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Option Exercise	M	57.27	2,000	114,540	14,306
Feb 11 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	239.96	600	143,976	1,875	2.5 K to 1.9 K (-24.24 %)
Feb 11 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	238.50	200	47,700	2,475	2.7 K to 2.5 K (-7.48 %)
Feb 11 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	237.51	700	166,257	2,675	3.4 K to 2.7 K (-20.74 %)
Feb 11 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	236.29	200	47,258	3,375	3.6 K to 3.4 K (-5.59 %)
Feb 11 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Sell	S	234.84	300	70,452	3,575	3.9 K to 3.6 K (-7.74 %)
Feb 11 2020	VRTX	VERTEX PHARMACEUTI ...	Lee Yuchun	Director	Buy	M	57.27	2,000	114,540	3,875	1.9 K to 3.9 K (+106.67 %)

Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 46 next >